Daniel B. Rubinstein is Chief Medical Officer of Airus Research, Inc. Previously, he was Medical Officer at the Center for Drug Evaluation and Research in the Division for Biological, Therapeutic and Oncologic products in the U.S. Food and Drug Administration (FDA). Currently Dr. Rubinstein is Staff Physician at the National Cancer Institute and a Member of the American Society of Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, and the Massachusetts Medical Society. He received a Medical degree and a Bachelor degree in Microbiology from the University of Illinois in Chicago.